These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9492550)

  • 1. [Clinicopathological study of multiple myeloma associated with hyperammonemia].
    Fujii S; Fukuda S; Sezaki T; Murakami M
    Rinsho Ketsueki; 1998 Jan; 39(1):27-33. PubMed ID: 9492550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of a multiple myeloma cell line, derived from a case associated with hyperammonemia].
    Kozuka T; Fukuda S; Imai T; Sezaki T
    Rinsho Ketsueki; 2000 Nov; 41(11):1220-5. PubMed ID: 11193443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Massive ascites as an initial sign, plasmacytoma of the cervical supine, and hyperammonemic consciousness disturbance in a patient with biclonal type multiple myeloma].
    Ohmoto A; Kohno M; Yasukawa K; Matsuyama R
    Rinsho Ketsueki; 1996 Apr; 37(4):346-51. PubMed ID: 8847807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-secretory primary plasma cell leukemia with hyperammonemia].
    Kawano F; Tsukamoto A; Satoh M; Sanada I; Shido T; Miura K; Murakami T; Kaneko H; Takeya M; Matsuzaki H
    Rinsho Ketsueki; 1991 Apr; 32(4):399-403. PubMed ID: 2067085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperammonemia in multiple myeloma.
    Matsuzaki H; Uchiba M; Yoshimura K; Yoshida M; Akahoshi Y; Okazaki K; Takatsuki K
    Acta Haematol; 1990; 84(3):130-4. PubMed ID: 2123062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Coma, hyperviscosity syndrome, hyperammonemia and myelofibrosis in a patient with IgG, lambda type multiple myeloma].
    Tsunoda S; Sasaki R; Miwa A; Sakurabayashi I; Miura Y
    Rinsho Ketsueki; 1989 Mar; 30(3):361-5. PubMed ID: 2504973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splanchnic circulation and metabolism in patients with acute liver failure.
    Clemmesen O
    Dan Med Bull; 2002 Aug; 49(3):177-93. PubMed ID: 12238280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple myeloma-associated amyloidosis manifesting as fulminant hepatic failure.
    Ales NC; Daniels JT; Frizell ER; Koff JM; Kaplan KJ; Wortmann GW
    South Med J; 2001 Oct; 94(10):1036-8. PubMed ID: 11702819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bence Jones type multiple myeloma showing diffuse infiltration to the dura mater by myeloma cells].
    Nomoto N; Saito H; Kashimura M; Aoki S; Shibata A
    Rinsho Ketsueki; 1995 Jul; 36(7):694-9. PubMed ID: 7563599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pathologic findings in 52 consecutively autopsied cases with multiple myeloma.
    Oshima K; Kanda Y; Nannya Y; Kaneko M; Hamaki T; Suguro M; Yamamoto R; Chizuka A; Matsuyama T; Takezako N; Miwa A; Togawa A; Niino H; Nasu M; Saito K; Morita T
    Am J Hematol; 2001 May; 67(1):1-5. PubMed ID: 11279649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A fatal case of aggressive-phase multiple myeloma with ileus and invasion into extramedullary organs].
    Takaya N; Miyakoshi S; Kubo K; Mutou Y; Endou Y
    Rinsho Ketsueki; 1998 May; 39(5):379-85. PubMed ID: 9637889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloma and severe cholestasis.
    Licht A; Maurer R; Oelz O
    Schweiz Med Wochenschr; 1999 Aug; 129(34):1201-4. PubMed ID: 10486860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperammonemia and encephalopathy in patients with multiple myeloma.
    Talamo G; Cavallo F; Zangari M; Barlogie B; Lee CK; Pineda-Roman M; Kiwan E; Krishna S; Tricot G
    Am J Hematol; 2007 May; 82(5):414-5. PubMed ID: 17133420
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe acute cholestatic hepatitis by infiltration of monoclonal plasma cells in multiple myeloma.
    Barth C; Bosse A; Andus T
    Z Gastroenterol; 2005 Oct; 43(10):1129-32. PubMed ID: 16220452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease.
    Hungria VT; Latrilha MC; Rodrigues DG; Bydlowski SP; Chiattone CS; Maranhão RC
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):51-60. PubMed ID: 14574458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver failure as the only clinical manifestation of multiple myeloma.
    Coffey D; Fain B; Thompson C; Chan ED; Nawaz S
    Ann Hematol; 2012 Apr; 91(4):625-7. PubMed ID: 21732087
    [No Abstract]   [Full Text] [Related]  

  • 17. [Multiple myeloma associated with hepatic infiltration: one case report].
    Maàmouri N; Bouzid H; Cheikh I; Hadj ZB; Mekni A; Bouaziz S; Belkahla N; Ouerghi H; Zitouna MM; Ben Mami N
    Tunis Med; 2008 Feb; 86(2):189-90. PubMed ID: 18444543
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical effect of human lymphoblastoid interferon in patients with multiple myeloma].
    Yoshida M; Ohta M; Muroi K; Takeda K; Kitagawa S; Tsuboyama A; Sakamoto S; Miura Y; Mutoh Y
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1394-8. PubMed ID: 6742866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aggressive myeloma with subcutaneous tumor and pericardial involvement].
    Takahashi R; Ashihara E; Hirata T; Okawa K; Oku N; Goto H; Inaba T; Fujita N; Shimazaki C; Nakagawa M
    Rinsho Ketsueki; 1994 Mar; 35(3):291-5. PubMed ID: 8158851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postictal transient hyperammonemia as an indicator of seizure disorder.
    Liu KT; Lee CW; Yang SC; Yeh IJ; Lin TJ; Su CS
    Eur Neurol; 2010; 64(1):46-50. PubMed ID: 20606448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.